title: Reversible cyclosporine arteriolopathy.
authors.affiliation: Department of Medicine, University of Washington School of Medicine, Seattle.
authors.forename: B S
authors.initials: BS
authors.lastname: Collins
authors.forename: C L
authors.initials: CL
authors.lastname: Davis
authors.forename: C L
authors.initials: CL
authors.lastname: Marsh
authors.forename: J P
authors.initials: JP
authors.lastname: McVicar
authors.forename: J D
authors.initials: JD
authors.lastname: Perkins
authors.forename: C E
authors.initials: CE
authors.lastname: Alpers
mesh_terms: D000328:Adult; D001160:Arterioles; D001706:Biopsy; D016572:Cyclosporine / Q000008:administration & dosage / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D015725:Fluconazole / Q000494:pharmacology; D006801:Humans; D007672:Kidney Cortex / Q000473:pathology; D016030:Kidney Transplantation / Q000009:adverse effects; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000187:drug effects; D016035:Pancreas Transplantation / Q000009:adverse effects; D014652:Vascular Diseases / Q000139:chemically induced
chemical_list: D016572:Cyclosporine; D015725:Fluconazole